Clinical Trial Update: Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating interleukin-7 in combination with a cancer vaccine for metastatic melanoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cancer vaccine therapy
• Interleukin-7 (interleukin-7)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED